Nussberger J, Brunner D B, Waeber B, Brunner H R
Division of Hypertension, University Hospital, Lausanne, Switzerland.
Life Sci. 1988;42(17):1683-8. doi: 10.1016/0024-3205(88)90448-1.
To prevent in vitro generation of angiotensins, the renin inhibitor CGP 29287 (CGP) was added to blood sampling tubes. Plasma immunoreactive angiotensin (ir-ANG) I and II were simultaneously measured by radioimmunoassay after rapid and quantitative extraction from a single plasma sample on phenylsilylsilica (Bondelut PH). True plasma ANG-(1-8)octapeptide was determined after additional separation of the different angiotensins by high performance liquid chromatography. Ir-ANG II/CGP showed the known linear relationship with ANG-(1-8)octapeptide (r = 0.87, n = 23), but - in contrast to studies without addition of CGP - the y-axis intercept which presumably represents cross-reacting angiotensins other than ANG II was very small. Ir-ANG II/CGP concentrations fell below 1 fmol/ml after converting enzyme inhibition. The results suggest that CGP 29287 prevents in vitro generation of ANG I and ANG II as well as the ANG-metabolites. Ir-ANG I/CGP measured after Bondelut PH extraction of the plasma was strongly correlated with ir-ANG I obtained after blood ethanol extraction (r = 0.97, n = 23). Thus, it is now possible to measure reliably both ANG I and ANG II within the same plasma extract after a simple extraction procedure.
为防止血管紧张素在体外生成,将肾素抑制剂CGP 29287(CGP)添加到血样采集管中。从单个血浆样本在苯基硅烷硅胶(Bondelut PH)上进行快速定量提取后,通过放射免疫分析法同时测定血浆免疫反应性血管紧张素(ir-ANG)I和II。在通过高效液相色谱法进一步分离不同的血管紧张素后,测定真实血浆ANG-(1-8)八肽。Ir-ANG II/CGP与ANG-(1-8)八肽呈现已知的线性关系(r = 0.87,n = 23),但与未添加CGP的研究相比,推测代表除ANG II之外的交叉反应性血管紧张素的y轴截距非常小。在转化酶抑制后,Ir-ANG II/CGP浓度降至1 fmol/ml以下。结果表明,CGP 29287可防止ANG I、ANG II以及ANG代谢产物在体外生成。在血浆经Bondelut PH提取后测得的Ir-ANG I/CGP与经血液乙醇提取后获得的ir-ANG I高度相关(r = 0.97,n = 23)。因此,现在通过简单的提取程序就可以在同一血浆提取物中可靠地测量ANG I和ANG II。